Edition:
United Kingdom

Syneos Health Inc (SYNH.OQ)

SYNH.OQ on NASDAQ Stock Exchange Global Select Market

49.10USD
21 Sep 2018
Change (% chg)

$0.20 (+0.41%)
Prev Close
$48.90
Open
$48.75
Day's High
$49.20
Day's Low
$48.50
Volume
446,125
Avg. Vol
177,725
52-wk High
$59.40
52-wk Low
$31.10

Latest Key Developments (Source: Significant Developments)

Syneos Health Acquires Kinapse
Monday, 20 Aug 2018 

Aug 20 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH™ ACQUIRES KINAPSE TO FURTHER ENHANCE END-TO-END CAPABILITIES.SYNEOS HEALTH INC - FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED..SYNEOS HEALTH INC - COMPANY EXPECTS TRANSACTION TO BE ACCRETIVE TO ITS EARNINGS.SYNEOS HEALTH INC - COMPANY REAFFIRMS 2018 GUIDANCE RANGE PROVIDED ON AUGUST 2, 2018.SYNEOS HEALTH INC - IS FUNDING TRANSACTION THROUGH CASH ON HAND.SYNEOS HEALTH INC - REMAINS COMMITTED TO ACHIEVING A NET LEVERAGE RATIO OF APPROXIMATELY THREE TIMES BY END OF 2019.  Full Article

INC Research Says CFO Greg Rush Resigned
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - INC Research Holdings Inc ::INC RESEARCH/INVENTIV HEALTH ANNOUNCES CFO TRANSITION.SAYS CFO GREG RUSH RESIGNED.- ‍RUSH WILL REMAIN AS COMPANY'S CFO UNTIL APRIL 30, 2018​.- JASON MEGGS WILL ACT AS INTERIM CFO, BEGINNING APRIL 30, 2018.  Full Article

Inc Research Holdings qtrly GAAP diluted loss per share of $1.70‍​
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Inc Research Holdings Inc :Qtrly GAAP diluted loss per share of $1.70‍​.Qtrly combined company adjusted diluted eps of $0.54‍​.Inc Research Holdings - Net service revenue for the three months ended September 30, 2017 increased by $332.7 million, or 128.2%, to $592.2 million‍​.Inc Research Holdings Inc sees Q4 net service revenue $738.0 million to $768.0 million​.Inc Research Holdings Inc sees ‍Q4 adjusted net service revenue 750.0 million to 780.0 million​.Inc Research Holdings Inc - In connection with the merger, we re-evaluated existing backlog policy for clinical solutions segment‍​.Inc Research Holdings Inc sees ‍Q4 adjusted diluted EPS $0.52 to $0.60​.Inc Research Holdings Inc - Effective during Q2 of 2017, changed policy for calculating and reporting amounts of net new business awards and backlog‍​.Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $2.59 -- Thomson Reuters I/B/E/S.Inc Research Holdings Inc sees ‍Q4 GAAP diluted loss per share $0.25 to $0.14​.Q4 earnings per share view $0.72, revenue view $809.5 million -- Thomson Reuters I/B/E/S.Inc Research Holdings Inc - Under new policy combined co clinical solutions backlog was adjusted from $4.80 billion to $3.72 billion as of September 30, 2017‍​.  Full Article